An 8-year-old neutered male Cocker Spaniel presents with ...

Ah, a classic presentation for a Cocker Spaniel, unfortunately. Severe acute pancreatitis in this breed can be particularly challenging, given their predisposition to hyperlipidemia and concurrent immune-mediated diseases. Your findings of acute vomiting, anorexia, severe abdominal pain (prayer position), markedly elevated cPLI (>1000 ug/L), leukocytosis, and hemoconcentration paint a clear picture of a critical patient.

The gold standard treatment for severe acute pancreatitis is primarily aggressive supportive care, focusing on five key pillars: fluid therapy, analgesia, antiemetics, early nutritional support, and careful monitoring.

Here's my recommended protocol:

Aggressive Intravenous Fluid Therapy:

* Goal: Correct dehydration, maintain perfusion, and address electrolyte imbalances. Pancreatitis patients are often profoundly dehydrated and can develop third-space fluid losses.
* Protocol: Start with a balanced crystalloid solution (e.g., LRS, Plasmalyte) at shock rates if hypotensive, then reduce to 1.5-2x maintenance. Monitor hydration parameters (PCV/TS, urine specific gravity, body weight, mucous membranes) closely, as well as electrolyte and acid-base status.
* Consideration: If the patient is severely hypoproteinemic or hypotensive despite crystalloids, a synthetic colloid (e.g., Vetstarch) or plasma transfusion may be considered, though the evidence for plasma's direct antiprotease effect is weak.

Potent Multimodal Analgesia:

* Goal: Pain management is paramount. Severe abdominal pain causes profound stress, contributes to anorexia, and can exacerbate systemic inflammatory response syndrome (SIRS).
* Protocol: Opioids are the cornerstone. I would initiate a fentanyl CRI (2-10 µg/kg/hr IV after a loading dose of 2-5 µg/kg IV) or hydromorphone (0.05-0.1 mg/kg IV/IM/SQ q4-6h).
* Adjunct: Maropitant (1 mg/kg SQ q24h) not only provides antiemetic effects but also has visceral analgesic properties. Gabapentin can be added for neuropathic pain component if refractory. NSAIDs are absolutely contraindicated due to renal perfusion concerns.

Effective Antiemetic Therapy:

* Goal: Control vomiting to prevent dehydration, electrolyte derangements, esophagitis, and promote comfort.
* Protocol: Maropitant (1 mg/kg SQ q24h) is the first-line choice. If vomiting persists, add ondansetron (0.5-1 mg/kg IV q8-12h).

Early Nutritional Support:

* Goal: This is critical. While historical protocols advocated NPO, current evidence strongly supports early enteral nutrition (within 24-48 hours) to maintain gut mucosal integrity, prevent bacterial translocation, and reduce the catabolic state.
* Protocol: If the patient is not vomiting and willing to eat, offer a highly digestible, ultra-low fat diet (e.g., Hill's i/d Low Fat, Royal Canin GI Low Fat). Start with small, frequent meals.
* Alternative: If anorexic or persistently vomiting despite antiemetics, consider placement of a nasoesophageal or nasogastric feeding tube. If the GI tract cannot be used (e.g., severe ileus, intractable vomiting), partial or total parenteral nutrition (PPN/TPN) may be necessary, but this carries higher risks and cost.
* Cobalamin: Many pancreatitis patients are cobalamin deficient. I would initiate cobalamin (B12) supplementation at 250-1500 mcg SQ weekly (dose by weight) for 6 weeks, then monthly.

Gastrointestinal Protectants (If Indicated):

* Goal: To prevent or treat gastric erosions/ulcers or esophagitis that can occur secondary to severe vomiting or stress.
* Protocol: Omeprazole (1 mg/kg PO BID) can be used, given 30 minutes before food.

Antibiotics:

* Goal: Only indicated if there is evidence of bacterial infection (e.g., septic peritonitis, positive culture from pancreatic aspirate, or severe systemic inflammatory response that cannot be explained by sterile pancreatitis alone).
* Protocol: Pancreatitis is typically a sterile inflammatory process. Routine antibiotic use is NOT recommended and can contribute to antibiotic resistance.

Monitoring:

* Acute Phase: Monitor PCV/TS, blood glucose, electrolytes, BUN/Cr, systemic blood pressure, urine output, and pain scores every 4-12 hours as dictated by severity.
* Longer Term: Once stable, monitor cPLI, albumin, and calcium. Hypercalcemia can be a trigger for pancreatitis, and hypocalcemia is a negative prognostic indicator.

Cocker Spaniels are also predisposed to hyperlipidemia, which can be a primary cause or exacerbating factor. Once the acute crisis is resolved, investigating and managing any underlying hyperlipidemia will be crucial to prevent recurrence.

This is a critical patient, and aggressive, proactive management is key to a positive outcome. I'd have high confidence in this comprehensive approach.